Susquehanna International Group
HZNP

Susquehanna International Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Susquehanna International Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-988,800
Closed -$114M – 13789
2023
Q3 		$114M Sell
988,800
-185,200
-16% -$19.9M 0.02% 564
2023
Q2 		$121M Buy
1,174,000
+603,300
+106% +$63.6M 0.02% 530
2023
Q1 		$62.3M Sell
570,700
-435,000
-43% -$48.1M 0.01% 823
2022
Q4 		$114M Buy
1,005,700
+921,400
+1,093% +$76.5M 0.03% 498
2022
Q3 		$5.22M Sell
84,300
-7,700
-8% -$538K ﹤0.01% 3093
2022
Q2 		$7.34M Sell
92,000
-27,100
-23% -$2.57M ﹤0.01% 2628
2022
Q1 		$12.5M Sell
119,100
-47,900
-29% -$4.67M ﹤0.01% 2259
2021
Q4 		$18M Buy
167,000
+27,400
+20% +$2.99M ﹤0.01% 1977
2021
Q3 		$15.3M Sell
139,600
-104,100
-43% -$10.8M ﹤0.01% 2289
2021
Q2 		$22.8M Sell
243,700
-55,700
-19% -$5.13M ﹤0.01% 1873
2021
Q1 		$27.6M Buy
299,400
+111,300
+59% +$9.39M ﹤0.01% 1542
2020
Q4 		$13.8M Sell
188,100
-76,600
-29% -$5.69M ﹤0.01% 2128
2020
Q3 		$20.6M Buy
264,700
+163,700
+162% +$11.3M ﹤0.01% 1457
2020
Q2 		$5.61M Sell
101,000
-48,000
-32% -$2.05M ﹤0.01% 2843
2020
Q1 		$4.41M Sell
149,000
-203,900
-58% -$6.9M ﹤0.01% 2749
2019
Q4 		$12.8M Buy
352,900
+270,400
+328% +$8.29M ﹤0.01% 1832
2019
Q3 		$2.25M Sell
82,500
-66,200
-45% -$1.71M ﹤0.01% 3972
2019
Q2 		$3.58M Buy
148,700
+6,300
+4% +$160K ﹤0.01% 3182
2019
Q1 		$3.76M Buy
142,400
+106,400
+296% +$2.52M ﹤0.01% 2812
2018
Q4 		$703K Buy
36,000
+1,900
+6% +$37.2K ﹤0.01% 5381
2018
Q3 		$668K Sell
34,100
-28,300
-45% -$538K ﹤0.01% 6016
2018
Q2 		$1.03M Sell
62,400
-164,000
-72% -$2.5M ﹤0.01% 5283
2018
Q1 		$3.21M Sell
226,400
-172,200
-43% -$2.54M ﹤0.01% 3145
2017
Q4 		$5.82M Sell
398,600
-162,300
-29% -$2.28M ﹤0.01% 2370
2017
Q3 		$7.11M Sell
560,900
-106,300
-16% -$1.35M ﹤0.01% 2108
2017
Q2 		$7.92M Buy
667,200
+6,900
+1% +$85.8K ﹤0.01% 1898
2017
Q1 		$9.76M Sell
660,300
-776,600
-54% -$12.6M ﹤0.01% 1656
2016
Q4 		$23.2M Buy
1,436,900
+76,800
+6% +$1.39M 0.01% 938
2016
Q3 		$24.7M Buy
1,360,100
+233,100
+21% +$4.55M 0.01% 874
2016
Q2 		$18.6M Buy
1,127,000
+569,600
+102% +$9.22M 0.01% 1018
2016
Q1 		$9.24M Sell
557,400
-751,800
-57% -$13.2M ﹤0.01% 1633
2015
Q4 		$28.4M Sell
1,309,200
-68,900
-5% -$1.34M 0.01% 899
2015
Q3 		$27.3M Buy
1,378,100
+848,600
+160% +$26.8M 0.01% 975
2015
Q2 		$18.4M Sell
529,500
-5,400
-1% -$165K 0.01% 1379
2015
Q1 		$13.9M Buy
534,900
+429,000
+405% +$7.86M 0.01% 1556
2014
Q4 		$1.36M Sell
105,900
-51,700
-33% -$647K ﹤0.01% 5242
2014
Q3 		$1.94M Buy
157,600
+49,900
+46% +$580K ﹤0.01% 4670
2014
Q2 		$1.7M Buy
107,700
+64,900
+152% +$926K ﹤0.01% 4971
2014
Q1 		$647K Sell
42,800
-6,600
-13% -$74.5K ﹤0.01% 6302
2013
Q4 		$376K Buy
49,400
+30,800
+166% +$166K ﹤0.01% 7209
2013
Q3 		$63K Buy
18,600
+1,800
+11% +$4.75K ﹤0.01% 8191
2013
Q2 		$41K Buy
+16,800
New +$40.3K ﹤0.01% 8018

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's HZNP Position: Q4 2023 in Review

Susquehanna International Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 347,967 shares — an estimated $40.3M sold.

Susquehanna International Group first reported a position in HZNP in Q2 2013 and held it in 37 quarters. The position peaked at $79.8M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Susquehanna International Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 347,967 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $40.3M.
  • Susquehanna International Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 37 quarters.
  • Susquehanna International Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $79.8M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.